The invention discloses a
spleen polypeptide extract extracted from the
spleen tissue of mammals other than humans. The
mammalian tissue is subjected to
fat removal, homogenization, acid adjustment, freezing and thawing, pH adjustment,
precipitation, heating, and
centrifugation.
Filtration,
ultrafiltration and other steps to obtain the
spleen polypeptide extract; the
drug is an
immunomodulatory drug that can improve and improve the immune function of the body, and can be used for primary and secondary cellular immune deficiency diseases (such as eczema, thrombocytopenia, multiple Infection syndrome, etc.),
respiratory tract and
lung infection, habitual cold,
chronic hepatitis B, mumps, recurrent aphtha and other diseases, can be used in the treatment of
leukopenia,
leukemia, aplastic
anemia caused by radiotherapy and
chemotherapy ,
Lymphoma and other malignant tumors, to improve the
malignant transformation of tumor patients, to improve postoperative or
critically ill patients when they are weak.